Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study

PURPOSE: Improvement in the control of delayed chemotherapy-induced nausea and vomiting (CINV) is needed. There is limited information on antiemetic prophylaxis for patients undergoing low-emetic-risk chemotherapy (LEC), and the optimal antiemetic treatment is not well understood. Therefore, we anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Toshinobu, Shimokawa, Mototsugu, Matsuo, Koichi, Miyoshi, Takanori, Toriyama, Yoko, Yokota, Chiaki, Taniguchi, Jun, Hanada, Kiyonori, Tsumagari, Kyouichi, Okubo, Noriko, Koutake, Yoshimichi, Sakata, Kohei, Kawamata, Yosei, Goto, Takashi, Tsurusaki, Yasufumi, Koyabu, Makiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177523/
https://www.ncbi.nlm.nih.gov/pubmed/30323680
http://dx.doi.org/10.2147/CMAR.S176574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177523/
https://www.ncbi.nlm.nih.gov/pubmed/30323680
http://dx.doi.org/10.2147/CMAR.S176574

Ejemplares similares